Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
kr1.20 Mil
% of Total Estimate Gain
257.57%

AB GLOBAL RISK ALLOCATION FUND, INC.'s Novo Nordisk AS Holding Summary

As of 2025-02-28, AB GLOBAL RISK ALLOCATION FUND, INC. held - shares of Novo Nordisk AS(OCSE:NOVO B), totaling N/A. This investment constitutes 0% of their stock portfolio, and AB GLOBAL RISK ALLOCATION FUND, INC. now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2019Q4. In addition, there have been 1 sales at an average price of kr647.77 for 2,568.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr441.20, AB GLOBAL RISK ALLOCATION FUND, INC.'s estimated gain on his OCSE:NOVO B holdings is kr1.20 Mil, reflecting a 257.57% gain to date.

AB GLOBAL RISK ALLOCATION FUND, INC. OCSE:NOVO B (kr441.20) Holding Chart

AB GLOBAL RISK ALLOCATION FUND, INC. OCSE:NOVO B (kr441.20) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1